Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check4 days agoChange DetectedA site-wide announcement says NIH websites are changing and that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error screen with an HTML skeleton and navigation, replacing the study record content. This indicates an access/availability issue rather than a substantive content update to the study listing.SummaryDifference17%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor platform update. It does not change the study data or visible content on the page.SummaryDifference0.1%

- Check81 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a software/template update to the ClinicalTrials.gov page. This change does not alter any study details, eligibility criteria, or reported results.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.